Dianthus Therapeutics (DNTH) Interest & Investment Income: 2017-2025
Historic Interest & Investment Income for Dianthus Therapeutics (DNTH) over the last 6 years, with Sep 2025 value amounting to $3.7 million.
- Dianthus Therapeutics' Interest & Investment Income fell 17.71% to $3.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.8 million, marking a year-over-year decrease of 6.18%. This contributed to the annual value of $17.4 million for FY2024, which is 264.50% up from last year.
- Per Dianthus Therapeutics' latest filing, its Interest & Investment Income stood at $3.7 million for Q3 2025, which was up 7.49% from $3.4 million recorded in Q2 2025.
- Dianthus Therapeutics' 5-year Interest & Investment Income high stood at $4.7 million for Q2 2024, and its period low was $416,000 during Q3 2022.
- Moreover, its 3-year median value for Interest & Investment Income was $3.7 million (2025), whereas its average is $3.0 million.
- As far as peak fluctuations go, Dianthus Therapeutics' Interest & Investment Income soared by 596.70% in 2024, and later fell by 27.72% in 2025.
- Dianthus Therapeutics' Interest & Investment Income (Quarterly) stood at $640,000 in 2022, then surged by 281.88% to $2.4 million in 2023, then spiked by 63.26% to $4.0 million in 2024, then decreased by 17.71% to $3.7 million in 2025.
- Its last three reported values are $3.7 million in Q3 2025, $3.4 million for Q2 2025, and $3.8 million during Q1 2025.